The double anaerobic threshold in heart failure: MECKI score database overview.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
08 2022
Historique:
revised: 25 02 2022
received: 07 02 2022
accepted: 14 03 2022
pubmed: 18 5 2022
medline: 20 7 2022
entrez: 17 5 2022
Statut: ppublish

Résumé

In heart failure (HF), anaerobic threshold (AT) may be indeterminable but its value held a relevant prognostic role. AT is evaluated joining three methods: V-slope, ventilatory equivalent, and end-tidal methods. The possible non-concordance between the V-slope (met AT) and the other two methods (vent AT) has been highlighted in healthy individuals and named double threshold (DT). We reanalysed 1075 cardiopulmonary exercise tests of HF patients recruited in the Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) score database. We identified DT in 43% of cases. Met AT precedes vent AT being met-ventΔVO Double threshold is frequently observed in HF patients. DT+ is associated to a decreased ventilatory response during exercise.

Identifiants

pubmed: 35579114
doi: 10.1002/ehf2.13920
pmc: PMC9288766
doi:

Substances chimiques

Carbon Dioxide 142M471B3J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2119-2124

Informations de copyright

© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

Am Rev Respir Dis. 1984 Feb;129(2 Pt 2):S49-55
pubmed: 6421218
Chest. 1999 Aug;116(2):355-62
pubmed: 10453862
Anesthesiol Clin. 2015 Mar;33(1):1-16
pubmed: 25701925
Eur J Heart Fail. 2014 Sep;16(9):929-41
pubmed: 25175894
Ann Am Thorac Soc. 2017 Jul;14(Supplement_1):S53-S58
pubmed: 28362512
Eur J Heart Fail. 2005 Jun;7(4):498-504
pubmed: 15921786
Circ Heart Fail. 2013 Sep 1;6(5):977-87
pubmed: 23881847
ESC Heart Fail. 2022 Aug;9(4):2119-2124
pubmed: 35579114
Int J Cardiol. 2013 Oct 3;168(3):2134-40
pubmed: 23506636
Int J Cardiol. 2013 Sep 10;167(6):2710-8
pubmed: 22795401
Eur J Heart Fail. 2018 Apr;20(4):700-710
pubmed: 28949086
Eur J Prev Cardiol. 2022 Mar 25;29(3):502-509
pubmed: 34160034
Int J Cardiol. 2022 Apr 15;353:68-70
pubmed: 35090987
Int J Cardiol. 2019 Aug 1;288:107-113
pubmed: 31047701
Chest. 2019 Aug;156(2):338-347
pubmed: 30926397
Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):249-67
pubmed: 19440156
Chest. 2007 Dec;132(6):1994-7
pubmed: 18079233
J Appl Physiol (1985). 1986 Jun;60(6):2020-7
pubmed: 3087938

Auteurs

Sara Rovai (S)

Department of Heart Failure and Clinical Cardiology, Centro Cardiologico Monzino, IRCCS, Via Parea 4, Milan, 20138, Italy.

Denise Zaffalon (D)

Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy.

Marco Cittar (M)

Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy.

Luca Francesco Felli (LF)

Università Bicocca, Milan, Italy.

Elisabetta Salvioni (E)

Department of Heart Failure and Clinical Cardiology, Centro Cardiologico Monzino, IRCCS, Via Parea 4, Milan, 20138, Italy.

Arianna Galotta (A)

Department of Heart Failure and Clinical Cardiology, Centro Cardiologico Monzino, IRCCS, Via Parea 4, Milan, 20138, Italy.

Irene Mattavelli (I)

Department of Heart Failure and Clinical Cardiology, Centro Cardiologico Monzino, IRCCS, Via Parea 4, Milan, 20138, Italy.

Cosimo Carriere (C)

Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy.

Massimo Mapelli (M)

Department of Heart Failure and Clinical Cardiology, Centro Cardiologico Monzino, IRCCS, Via Parea 4, Milan, 20138, Italy.

Marco Merlo (M)

Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy.

Carlo Vignati (C)

Department of Heart Failure and Clinical Cardiology, Centro Cardiologico Monzino, IRCCS, Via Parea 4, Milan, 20138, Italy.

Gianfranco Sinagra (G)

Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy.

Piergiuseppe Agostoni (P)

Department of Heart Failure and Clinical Cardiology, Centro Cardiologico Monzino, IRCCS, Via Parea 4, Milan, 20138, Italy.
Department of Clinical Sciences and Community Health, Cardiovascular Section, University of Milan, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH